Cellular Health screening are the tests used to determine Cellular health and function, Cellular toxicity, fat mass, Active tissue mass (muscle mass), Intra and extracellular fluid levels, the quality and quantity of muscle mass. Cell health encompasses many aspects of cellular function, including viability, growth, apoptosis, cytotoxicity and proliferation. Cellular Health Screening also helps to monitor the progress throughout the treatment period. Different reagents, imaging systems are used for cellular health screening. Cell screening test are of two types, such as single cell screening and multicellular screening. Molecular Devices also offers technologies that enable researches to conduct innovative, thorough cellular analyses. Microplate readers examine all cells in each well of a microplate for higher throughput, while high-content analysis (HCA) systems provide more detailed information at the cellular and subcellular levels.
Driving Factors such as, growing number of chronic diseases, growing awareness among people and early adoption of treatment procedures, government insurance coverage and developing healthcare infrastructure will drive the global cellular health screening market. According to American cancer society, in 2017, nearly 13% of cancers diagnosed in adults ages 20. Rising geriatric population, growing demand for test procedures are another factors which will add value to the global cellular health screening market. On the other hand the large number of key players and market competitiveness may hinder the market growth.
The Cellular Health Screening Market has been segmented by product type, by Test type, by End users and by geography. In terms of product type Cellular Health Screening market is classified in to Imaging Systems, Reagents, In Situ Hybridization (ISH) and others. Imaging system is again classified into Transmitted-Light/Colorimetric Imaging, Fluorescence Imaging, Simplified Automated Imaging and EVOS Cell Imaging. In terms of Test type Cellular Health Screening market is classified into Telomere Tests, Oxidative Stress Tests, Infectious disease Tests, Heavy Metal Tests, Others. In terms of End users Cellular Health Screening market is classified into Hospital, Clinics, Diagnostic Laboratory and Others.
Geographically Cellular Health Screening market is classified into North America, Latin America, Europe, Asia Pacific, Middle East and Africa.
Geographically North America dominates the Cellular Health Screening market due to growing government attention towards preventive healthcare, increasing research activities, rising geriatric population, growing number of local players operating in the region and increasing burden of chronic diseases will drive the Cellular Health Screening market. According to Population Reference Bureau, The number of Americans ages 65 and older is estimated to reach from 46 million to approximately 98 million by 2060. Europe is the second largest market for Cellular Health Screening Market due to increasing number of research and development activities, increasing burden of chronic diseases and initiatives to create awareness about cellular biomarkers. Asia Pacific region is expected to grow at higher rate due to growing awareness among people, developing healthcare infrastructure, growing economy and increasing number of infectious diseases will drive the Cellular Health Screening market. According to the World Bank, China’s economy will grow 6.5% in 2017 and 6.3% in 2018, compared with 6.7% in 2016, as the government rebalances toward consumption and services. Emerging region such as Latin America and Middle East and Africa will create a large opportunity for global cellular health screening market due to growing awareness among people, increasing public and private healthcare insurance coverage, government initiatives and increasing healthcare investment.
The major players operating in this market include Thermo Fisher Scientific, Cell Biolabs, Inc., PerkinElmer Inc., Beckman Coulter, Inc., F. Hoffmann-La Roche AG, Advanced Cell Diagnostics, Inc., Abbott Laboratories, Inc., and Quest Diagnostics among other significant players worldwide.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.